Abstract: The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds.

Abstract: Disclosed in certain embodiments is a method of treating infections of an interior part of the human or animal body, comprising administering to said interior body part, a pharmaceutical preparation comprising a particulate carrier and an effective amount of an agent selected from the group consisting of an antiseptic agent, a wound-healing promoting agent and a combination thereof, to treat an infection at said interior body part.

Abstract: Use of an anti-infective and/or anti-inflammatory agent for the preparation of a pharmaceutical composition for the treatment of diseases of external or internal parts of the human or animal body which are susceptible to the administration of such agents.

Abstract: Use of an anti-inflammatory agent such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the lower respiratory tract which are susceptible to the administration of such agents.

Abstract: Disclosed are compositions comprising antiseptic and wound healing agents for the treatment of diseases of the lower respiratory tract and methods.

Abstract: Use of anti-inflammatory agents such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the upper respiratory tract and/or the ear which are susceptible to the administration of such agents.

Abstract: Disclosed in certain embodiments is a controlled release dosage form comprising a matrix comprising a pharmaceutically acceptable salt of an opioid analgesic in a controlled release material; wherein less than 25% of the opioid salt is released after 1 hour of in-vitro dissolution of the dosage form in 900 ml of Simulated Gastric Fluid with 20% ethanol using a USP Apparatus I (basket) apparatus at 100 rpm at 37 degrees C.°.

Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).

Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).

Abstract: In this invention, a wireless terminal location is monitored and used to locate providers of a requested service that are proximate to the location of the wireless terminal. At least one of the providers located is selected and identified by name and/or telephone number and/or the location, etc., and this information is delivered to and stored in the directory of the wireless terminal. The process is repeated as necessary to update the list of service providers when the wireless terminal is transported to a new location area. The service providers located can represent any category of service desired such as emergency facilities (especially in a foreign country) such as paramedics, hospital, police, or roadside assistance, etc.

Abstract: The invention concerns a method for the production of a pharmaceutical preparation for the treatment of acne forms that is characterized in, that the preparation comprises at least one antiseptic compound associated with a particular carrier.

Abstract: The invention concerns a method for the production of a pharmaceutical preparation for the treatment of Herpes forms that is characterized in, that the preparation comprises at least one anti-septic compound associated with a particular carrier.

Abstract: A packet encapsulation scheme for multiplexing application sessions—Lightweight IP Encapsulation (LIPE)—is described. An LIPE packet comprises at least one multiplexing header (NH) and associated multimedia data packet (MDP). The LIPE packet uses UDP/IP as transport. An MH field further comprises a 16-bit a user identifier (UID) field, an 11 bit length indicator (LNG) field, a 1 bit “more” (M) field and an optional payload type/class of service (PT/CoS) field comprising 8 bits.

Abstract: The present invention is directed to a storage stable package of a iodophor containing particulate pharmaceutically acceptable carrier compositions. The invention is particularly directed to a storage stable package of a PVP-iodine liposome compositions. The packaging material is generally plastic, paper or cardboard.

Abstract: Disclosed in certain embodiments is a method of treating pain in a patient comprising orally administering an opioid antagonist in an effective amount to provide analgesia in a patient in need thereof.

Abstract: The invention relates to a method for reducing the spread of computer viruses in an electronic mail network. In a mail server having a multiplicity of connected email subscriber computers, a method is installed which is used to test emails sent in succession to the subscribers or sent in succession by the subscribers for particular commonalities, and, depending on commonalities established, either to forward the emails automatically as intended or to retain them until another criterion arises.

Abstract: A portable device for dispensing a length of a matrix-controlled transdermal delivery system having a dose of active agent having a carriage device for supporting a first length of matrix-controlled transdermal delivery system; a unit for entering a dose amount and transposing the dose amount into a second length of the matrix-controlled transdermal delivery system; a separating device for separating the second length of matrix-controlled transdermal delivery system from the first length of matrix-controlled transdermal delivery system; and a locking mechanism that can be activated or deactivated by entering a user code.

Abstract: In this invention, a wireless terminal location is monitored and used to locate providers of a requested service that are proximate to the location of the wireless terminal. At least one of the providers located is selected and identified by name and/or telephone number and/or the location, etc., and this information is delivered to and stored in the directory of the wireless terminal. The process is repeated as necessary to update the list of service providers when the wireless terminal is transported to a new location area. The service providers located can represent any category of service desired such as emergency facilities (especially in a foreign country) such as paramedics, hospital, police, or roadside assistance, etc.

Abstract: A system for providing intelligent personalized customer service to a wireless terminal in a wireless telecommunication network is disclosed. Wireless terminal location is monitored and used to determine location-specific customer service information that is specific to the wireless terminal. The customer service information is delivered to the wireless terminal and displayed in human-readable form. The process is repeated as necessary to update the customer service information whenever the wireless terminal travels to a new location area.

Abstract: The present invention relates to liposomal pharmaceutical preparations which include active agents such as antiseptic agents, wound-healing agents, or combinations thereof, useful in the treatment of external wounds. The active agents are encapsulated in liposomes, and the liposomes are incorporated in pharmaceutical preparations such as liquids, ointments, gels, lotions, or creams capable of delivering the active agents to external wound sites. The invention further relates to methods of preparation of the liposomes and the pharmaceutical preparations, and to methods of treatment of external wounds and ophthalmic infections.